Totals
- Total revenue
- $2,494,481
- Total expenses
- $1,374,478
- Contributions and grants received
- $2,494,411
- Grants paid
- $1,009,000
- Program service revenue
- $0
- Investment income
- $70
- Other revenue
- $0
- Total assets, end of year
- $1,170,913
- Total liabilities, end of year
- $45,411
- Net assets or fund balances, end of year
- $1,125,502
- Program services expenses (Part IX)
- $1,222,303
- Management and general expenses
- $56,042
- Fundraising expenses
- $96,133
- Program service expenses (Part III)
- $1,222,303
Program services were 88.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$2,494,411
-
3 · Investment income
total $70 · excluded $70
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6d · Net rental income or loss
total $0
-
7d · Net gain or loss
total $0
-
8c · Net income from fundraising events
total $0
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $976,000 · program services $976,000
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $33,000 · program services $33,000
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $0
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $131,319 · program services $100,072 · management and general $3,677 · fundraising $27,570
-
8 · Pension plan contributions
total $22,298 · program services $16,992 · management and general $624 · fundraising $4,682
-
9 · Other employee benefits
total $0
-
10 · Payroll taxes
total $82,420 · program services $62,808 · management and general $2,307 · fundraising $17,305
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $0
-
11c · Fees: accounting
total $33,876 · management and general $33,876
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $30,110 · fundraising $30,110
-
12 · Advertising and promotion
total $0
-
13 · Office expenses
total $2,421 · program services $279 · management and general $2,142
-
14 · Information technology
total $0
-
15 · Royalties
total $0
-
16 · Occupancy
total $0
-
17 · Travel
total $29,466 · program services $28,843 · management and general $623
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $0
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $5,571 · program services $4,309 · management and general $1,262
-
23 · Insurance
total $4,368 · management and general $4,368
-
24a · Other expenses: Event & Fundraising Activities
total $16,466 · fundraising $16,466
-
24b · Other expenses: Website, internet, relations
total $3,923 · management and general $3,923
-
24c · Other expenses: Bank and credit card charges
total $2,115 · management and general $2,115
-
24d · Other expenses: Dues and subscriptions
total $1,125 · management and general $1,125
-
24e · All other expenses
total $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $199,339 · end of year $445,581
-
2 · Savings and temporary cash investments
beginning of year $73,271 · end of year $30,282
-
3 · Pledges and grants receivable
beginning of year $350,000 · end of year $333,334
-
4 · Accounts receivable
end of year $0
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $6,480 · end of year $13,165
-
10a · Land, buildings and equipment: cost or other basis
$50,382
-
10b · Land, buildings and equipment: accumulated depreciation
$22,344
-
10c · Land, buildings and equipment, net
beginning of year $3,674 · end of year $28,038
-
11 · Investments: publicly traded securities
end of year $0
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
end of year $320,513
-
17 · Accounts payable and accrued expenses
beginning of year $35,217 · end of year $45,411
-
18 · Grants payable
beginning of year $579,228
-
27 · Net assets without donor restrictions
beginning of year -$231,681 · end of year $471,655
-
28 · Net assets with donor restrictions
beginning of year $250,000 · end of year $653,847
Mission and programs · 2022
Mission
Canary Foundation is a public charity exempt from U.S. federal income tax under Section 501(c)(3) of the Internal Revenue Code in the United States. Canary Foundation of Canada is a Public Foundation registered with the Canada Revenue Agency; Business Number 82906 8550 RROOO1.The Canary Foundation has assembled teams of cancer researchers recognized by their peers as leaders in their disciplines from across multiple institutions and disciplines to attack the problem of early detection in a new, collaborative, action-oriented manner with the foremost objective of translating research into clinical applications. Canary differentiators include: * Dedication to early detection * Leaders in collaborative science * Focused and managed research * Best-in-class talent * 100% of donations goes to researchOne of the first decisions the Science Team made was to choose ovarian cancer as a prototype for creating an early detection blood test to detect trace amounts of proteins called biomarkers pro
Activities or mission (Part I)
Canary Foundation is the world's first non-profit organization dedicated solely to the funding, discovery and development of tests for early cancer detection.
-
The goal of the Canary Scientific Programs is to develop blood tests and imaging tests that can together be used to detect lethal cancers at a curable stage. Our plan for early and accurate cancer detection involves first screening patients with a blood test and then moving those patients who tested positive to a high-resolution imaging test to further isolate cancer so that it can be removed. Canary Foundation is focused on five cancer types, each of which presents a significant opportunity to save lives and prevent unnecessary treatments through early detection of otherwise lethal disease: cancer of the ovary, pancreas, lung, breast and prostate. Chances of survival are highest when cancer is detected before it spreads. Thus, accurate detection of cancer that would otherwise be lethal at its earliest stage promises to dramatically improve survival after diagnosis. Canary supports early detection
Expenses $1,222,303 · Grants $1,009,000
-
research programs in each of these cancer areas as well as a Collaborations Program with collaborating early detection programs and centers that include the Canary Center at Stanford for Cancer Early Detection.Canary Ovarian Cancer Program: The goal of our ovarian research program is to develop a strategy to accurately identify ovarian cancers that would otherwise be lethal at a stage when they are readily curable. Our vision is of a two-stage screening strategy, consisting of a simple blood test followed by a molecular imaging test. Development of blood and imaging tests follows a similar roadmap; both include biomarker discovery followed by validation, but they also involve different techniques and challenges.
-
Canary Lung Cancer Program:Canary is focused on developing diagnostics with high sensitivity and specificity to detect otherwise lethal lung cancers at a stage when they are readily curable. To this end, Canary has assembled a team of experts who are collaborating to discover and validate biomarkers for blood and imaging tests that together will identify individuals harboring lethal lung cancers so that they can be removed.The Canary Lung Cancer Program has supported the development and maintenance of critical biospecimen resources, blood biomarker discovery and validation, molecular imaging projects for early detection of lethal lung cancer, and epidemiology and modeling for effective lung cancer screening. (Continued on Schedule O)
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Heidi Auman
Program Manager
- Total calculated
- $188,500
- From this org
- $168,000
- From related orgs
- $0
- Other
- $20,500
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $168,000
- Bonus
- not reported
- Other
- not reported
- Deferred
- $20,500
- Nontaxable benefits
- not reported
- Filer's total
- $188,500
-
Don Listwin
Founder & CEO
- Total calculated
- $0
- Hours/week
- 8
-
Kevin Kennedy
Treasurer
- Total calculated
- $0
- Hours/week
- 4
-
Michael Ball
Director
- Total calculated
- $0
- Hours/week
- 4
-
Dale Jantzen
Director
- Total calculated
- $0
- Hours/week
- 4
-
Hilary Valentine
Director
- Total calculated
- $0
- Hours/week
- 4
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$704,000
Cancer Research
-
$50,000
Cancer Research
-
$40,000
Cancer Research
-
$40,000
Cancer Research
-
Seattle Inst Biomedical Clinical
$37,000
Cancer Research
-
$31,500
Cancer Research
-
$25,000
Cancer Research
-
$22,500
Cancer Research
-
$17,000
Cancer Research
-
$9,000
Cancer Research
The 10 largest by cash amount. The API serves every itemized grant.
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 12 July 2023
- IRS schema version
- 2022v5.0
- Source object
- 202321939349301912
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.